Elevation of the Cortisol-Dehydroepiandrosterone Ratio in Drug-Free Depressed Patients
- 1 July 2002
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 159 (7) , 1237-1239
- https://doi.org/10.1176/appi.ajp.159.7.1237
Abstract
OBJECTIVE: Elevated basal cortisol levels are a feature of depressive illness and cause deficits in learning and memory. The adrenal steroid dehydroepiandrosterone (DHEA) has antiglucocorticoid properties that may offer protection against the deleterious effects of cortisol. The authors examined the ratio of cortisol to DHEA in drug-free depressed patients and a matched comparison group. METHOD: Cortisol and DHEA were measured in saliva samples from 39 patients with unipolar depression who had been medication free for at least 6 weeks and 41 healthy comparison subjects. RESULTS: The molar cortisol-DHEA ratio was significantly higher in the depressed patients than in the healthy comparison subjects. Cortisol-DHEA ratios from saliva samples taken at 8:00 p.m. correlated positively with length of current depressive episode. CONCLUSIONS: Elevated cortisol-DHEA ratios may be a state marker of depressive illness and may contribute to the associated deficits in learning and memory. Administration of DHEA or othe...Keywords
This publication has 9 references indexed in Scilit:
- Altered salivary dehydroepiandrosterone levels in major depression in adultsBiological Psychiatry, 2000
- Glucocorticoids and Hippocampal Atrophy in Neuropsychiatric DisordersArchives of General Psychiatry, 2000
- Dehydroepiandrosterone sulfate (DHEAS) counteracts decremental effects of corticosterone on dentate gyrus LTP. implications for depressionBrain Research Bulletin, 2000
- The effects of chronic administration of hydrocortisone on cognitive function in normal male volunteersPsychopharmacology, 1999
- Assessing dehydroepiandrosterone in saliva: a simple radioimmunoassay for use in studies of children, adolescents and adultsPsychoneuroendocrinology, 1999
- Double-Blind Treatment of Major Depression With DehydroepiandrosteroneAmerican Journal of Psychiatry, 1999
- Neuroactive Neurosteroids as Endogenous Effectors for the Sigma1 (.SIGMA.1) Receptor. Pharmacological Evidence and Therapeutic Opportunities.The Japanese Journal of Pharmacology, 1999
- Dehydroepiandrosterone (DHEA) treatment of depressionBiological Psychiatry, 1997
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979